• Nenhum resultado encontrado

Overlapping DNA methylation dynamics in mouse intestinal cell differentiation and early stages of malignant progression.

N/A
N/A
Protected

Academic year: 2017

Share "Overlapping DNA methylation dynamics in mouse intestinal cell differentiation and early stages of malignant progression."

Copied!
22
0
0

Texto

Loading

Imagem

Fig 1. Simplified scheme of the experimental design to identify differential DNA methylation in intestinal cell differentiation and cancer
Fig 2. Genomic representativeness of AIMS-Seq. A, Mouse genome composition according to the different genetic elements considered
Fig 3. AIMS-Seq analysis. A, Distribution of normalized reads obtained by AIMS-Seq in the genomic region neighboring the Slitrk1 gene
Table 1. Differentially methylated regions (DMR) as determined by AIMS-Seq during intestinal cell differentiation and transformation.
+4

Referências

Documentos relacionados

MiRNA expression and DNA methylation changes were also investigated in FACS sorted CD44 high oral cancer stem cells from primary tumor samples (CSCs), and in oral rinse.. and

Second, we measured their DNMT activity in a rebound DNA methylation assay: DNA methylation was stripped from Cre/ loxP conditionally mutant Dicer1 ES cells using a shRNA

Thus, the aim of this study was to evaluate the COX-2 gene methylation pro- file and expression in gastric mucosa samples at different pathogenic stages of intestinal gastric cancer

Furthermore, besides considering changes in DNA methylation as mechanisms of disease, the role of epigenetics in general and DNA methylation in particular in

Regardless of their widely known cytokine gene expression proper- ties, NFATs have been shown to regulate other genes related to cell cycle progression, cell differentiation

The KRT14 gene DNA methylation analysis was performed using Methylation-Specific PCR (MSP), and the KRT19 gene DNA methylation analysis was performed

We hypothesised that genetic variants within genes responsible for maintenance of DNA methylation ( DNMT1 ) and for de novo DNA methylation ( DNMT3B ) alter

We evaluated the DNA methylation status of ANAPC1 , CDKN2A and TP53 by methylation-specific PCR in 20 diffuse- and 26 intestinal-type gastric cancer samples and 20 normal